Епігенетичні фактори як предиктори змін репродуктивного здоров’я у жінок фертильного віку з порушеннями вегетативного гомеостазу

Вл. В. Подольський

doi:10.18370/2309-4117.2015.22.58-61

Authors

Вл. В. Подольський Institute of Pediatrics, Obstetrics and Gynecology of the State Academy of Medical Science of Ukraine, Ukraine

DOI:

https://doi.org/10.18370/2309-4117.2015.22.58-61

Keywords:

women of fertile age, reproductive health, violations of autonomic homeostasis, epigenetic factors

Abstract

Epigenetic factors of beginning or exacerbation of autonomic homeostasis violations in women of fertile age that may be considered as predictors of changes in reproductive health were studied.

In particular, epigenetic risk factors of such violations in women with impaired autonomic homeostasis include smoking, excessive drinking, excessive drugs and psychotropic substances use and other factors that may be taken into account at health-care measures

Author Biography

Вл. В. Подольський, Institute of Pediatrics, Obstetrics and Gynecology of the State Academy of Medical Science of Ukraine

PhD, head of the research group, senior researcher, head of the Health Problems of Women of Childbearing Age Department

References

Zaporozhan, V.M., Mishchenko, V.P., Rudenko, I.V. “Current views on the diagnosis of gestational complications.” Proceedings Collection of the Association of Gynecologists and Obstetricians of Ukraine. Kyiv. Intermed (2011): 369–372.
Podolskyi, V.V. “Women's reproductive health – the most important issue of our time.” Women's Health, 1(13) (2003): 100–102.
Autonomic dysfunction: clinical features, diagnostics, treatment / Ed. by A.M. Vein. Moscow. Medical News Agency LTD (2003): 752 p.
Podolskyi, V.V. “Reproductive health disorders of autonomic homeostasis.” Women's Health, 9(85) (2013): 139–142.
Baranov, V.S. “Genetic basis of susceptibility to some common multifactorial diseases.” Medical Genetics, 3(3) (2004): 102–112.
Baranov, V.S., Baranova, V.E., Ivashchenko, T.E., Asieev, M.V. Human genome and susceptibility genes. Introduction to predictive medicine. SPb. Intermedika (2000): 271 p.
N ebert, D.V. “Polymorphisms in drug metabolizing enzymes: what is their clinical relevance and why do they exist?” Am J Hum Genet, 60(1997): 265–271.
T empfer, C.B., Simoni, M., Destenaves, B., Fauser, J.M. “Functional genetic polymorphisms and female reproductive disorders: Part II – endometriosis.” Human Reproduction Update, 1(15) (2009): 97–118.
A pplications of human genome epidemiology to environmental health. Human genome epidemiology // M.J. Khoury, J. Little, W. Burke, eds. Oxford University Press (2004): 145–167.
Gelatti, U., Covolo, L., Talamini, R., et al. “N-acetyltransferase-2, glutathione S-transferase M1 and T1 genetic polymorphisms, cigarette smoking and hepatocellular carcinoma: a case control study.” Int J Cancer, 6(2005): 301–306.
Podolskyi, V.V., Shkiriak-Nizhnik Z.A., Gorovenko, N.G., Dronova, V.L., et al. “Women's reproductive health and the assessment of its status in modern conditions.” Women's Health, 3(11) (2002): 111–117.
Podolskyi, V.V., Teterin, V.V., Gulchiy, L.P., Didychenko, V.M. “Features of epidemiological studies to determine the reproductive health of childbearing age women in the industrial area.” Bulletin of Scientific Researches, 1(30) (2003): 56–58.
W ang, X., Zuckerman, B., Kaufman, G., et al. “Molecular epidemiology of preterm delivery: methodology and challenges.” Paediatr Perinat Epidemiol, 2(15) (2001): 63–77.
E aton, D.L., Bammler, T.K. “Concise Review of the Glutathione S-Transferases and their Significance to Toxicology.” ToxicolScienc, 49(1999): 156–164.
Genetic passport as the basis of individual and predictive medicine / Ed. by V.S. Baranov. SPb. Publishing House H-L (2009): 528 p.